Disease modifying therapies and Covid-19 severity in Multiple Sclerosis. Sormani MP, De Rossi N, Schiavetti I, Carmisciano L, et al. Ann Neurol 2021 Jan 21. doi: 10.1002/ana.26028.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sormani MP, De Rossi N, Schiavetti I, Carmisciano L, et al. Disease modifying therapies and Covid-19 severity in Multiple Sclerosis. Ann Neurol 2021 Jan 21. doi: 10.1002/ana.26028.
PMID: 33480077